Study reveals how uncertainty wording sways cancer drug decisions
NCT ID NCT07110597
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study surveyed over 3,000 US adults to see if short statements about the unknowns in new cancer drug benefits and risks change how people decide on treatment. Participants imagined being a patient with lung cancer and rated how likely they would take a new drug after reading different uncertainty messages. The goal was to learn how to communicate drug uncertainties clearly without misleading patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London School of Economics and Political Science
London, United Kingdom
Conditions
Explore the condition pages connected to this study.